Biogen Inc (BIIB)
202.46
+0.47
(+0.23%)
USD |
NASDAQ |
Apr 25, 16:00
202.68
+0.22
(+0.11%)
After-Hours: 05:47
Biogen Total Return Price: 202.46 for April 25, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
April 25, 2024 | 202.46 |
April 24, 2024 | 201.99 |
April 23, 2024 | 193.18 |
April 22, 2024 | 194.11 |
April 19, 2024 | 194.38 |
April 18, 2024 | 190.52 |
April 17, 2024 | 192.16 |
April 16, 2024 | 195.15 |
April 15, 2024 | 196.80 |
April 12, 2024 | 198.18 |
April 11, 2024 | 203.68 |
April 10, 2024 | 201.55 |
April 09, 2024 | 206.52 |
April 08, 2024 | 204.95 |
April 05, 2024 | 203.87 |
April 04, 2024 | 205.30 |
April 03, 2024 | 206.38 |
April 02, 2024 | 207.64 |
April 01, 2024 | 214.83 |
March 28, 2024 | 215.63 |
March 27, 2024 | 216.34 |
March 26, 2024 | 212.02 |
March 25, 2024 | 216.69 |
March 22, 2024 | 218.10 |
March 21, 2024 | 220.75 |
Date | Value |
---|---|
March 20, 2024 | 218.15 |
March 19, 2024 | 218.63 |
March 18, 2024 | 219.40 |
March 15, 2024 | 219.31 |
March 14, 2024 | 219.62 |
March 13, 2024 | 226.56 |
March 12, 2024 | 227.36 |
March 11, 2024 | 230.07 |
March 08, 2024 | 223.24 |
March 07, 2024 | 219.36 |
March 06, 2024 | 217.56 |
March 05, 2024 | 217.23 |
March 04, 2024 | 221.02 |
March 01, 2024 | 220.95 |
February 29, 2024 | 216.99 |
February 28, 2024 | 221.74 |
February 27, 2024 | 223.94 |
February 26, 2024 | 223.71 |
February 23, 2024 | 223.32 |
February 22, 2024 | 222.48 |
February 21, 2024 | 221.11 |
February 20, 2024 | 219.21 |
February 16, 2024 | 219.08 |
February 15, 2024 | 223.35 |
February 14, 2024 | 220.74 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
187.54
Minimum
May 09 2022
414.71
Maximum
Jun 10 2021
263.51
Average
267.21
Median
Mar 23 2021
Total Return Price Benchmarks
Eli Lilly and Co | 724.87 |
Bristol-Myers Squibb Co | 44.70 |
Gilead Sciences Inc | 65.27 |
AbbVie Inc | 167.29 |
Regeneron Pharmaceuticals Inc | 890.68 |